🇺🇸 sufentanil-ropivacaine combination in United States

sufentanil-ropivacaine combination (sufentanil-ropivacaine combination) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

sufentanil-ropivacaine combination in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is sufentanil-ropivacaine combination approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for sufentanil-ropivacaine combination in United States?

Peking University First Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.